首页> 美国政府科技报告 >Mixed Lineage Kinases as Novel Targets for the Treatment of Endocrine-Resistant, ER-Positive Breast Cancer.

【24h】

Mixed Lineage Kinases as Novel Targets for the Treatment of Endocrine-Resistant, ER-Positive Breast Cancer.

机译：混合谱系激酶作为治疗内分泌抗性，ER阳性乳腺癌的新靶点。

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者
Conrad, S. E.;
展开▼
作者单位

展开▼
年度 2016
页码 1-11
总页数 11
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt/β2-catenin pathway [J] . FungT.K., GandilletA., SoC.W.E. Current opinion in hematology . 2012,第4期

机译：通过靶向糖原合酶激酶3和经典的Wnt /β2-catenin途径选择性治疗混合型白血病白血病干细胞
2. ADAM22 as a prognostic and therapeutic drug target in the treatment of endocrine-resistant breast cancer [J] . BolgerJ.C., YoungL.S. Vitamins and hormones. . 2013,第Null期

机译：ADAM22作为治疗内分泌耐药性乳腺癌的预后药物
3. Correction: Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1 [J] . Subhasis Das, Rakesh Sathish Nair, Rajakishore Mishra, Oncogene . 2019,第3期

机译：校正：混合谱系激酶3通过磷酸化和激活p21激活的激酶1促进乳腺肿瘤发生
4. Mixed-lineage kinase domain-like (MLKL) is a novel pseudokinase regulator of haematopoietic stem cell function, which modulates JAK2 signalling [C] . Murphy J.M., Tannahill G.M., Majewski I.J. Incorporating of the Australian Society for Biochemistry and Molecular Biology Combio . 2009

机译：混合谱系激酶域样（MLK1）是一种新型纯化干细胞功能的伪转酶调节剂，其调节JAK2信号传导
5. Dissecting the Role of Mixed Lineage Kinase 3 (MLK3) in Breast Cancer Invasion and Metastasis [D] . Rattanasinchai, Chotirat. 2017

机译：剖析混合谱系激酶3（MLK3）在乳腺癌侵袭和转移中的作用
6. Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis [O] . Limin Wang, Kathleen A. Gallo, Susan E. Conrad 2013

机译：在ER阳性乳腺癌细胞中靶向混合谱系激酶导致G2 / M细胞周期停滞和凋亡
7. Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase [O] . Stephen J. Crocker, Shawn P. Hayley, Patrice D. Smith, 2006

机译：通过靶向抑制CDC42或混合谱激酶的靶向多巴胺能神经元死亡和C-Jun磷酸化的调节

Mixed Lineage Kinases as Novel Targets for the Treatment of Endocrine-Resistant, ER-Positive Breast Cancer.

著录项

相似文献

相关主题

期刊订阅